Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Other Non-Current Liabilities (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Other Non-Current Liabilities for 6 consecutive years, with $154000.0 as the latest value for Q3 2018.

  • Quarterly Other Non-Current Liabilities fell 61.5% to $154000.0 in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $154000.0 through Sep 2018, down 61.5% year-over-year, with the annual reading at $292000.0 for FY2017, 88.05% down from the prior year.
  • Other Non-Current Liabilities hit $154000.0 in Q3 2018 for Armata Pharmaceuticals, down from $185000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $20.1 million in Q1 2014 to a low of $2000.0 in Q1 2016.
  • Historically, Other Non-Current Liabilities has averaged $3.9 million across 5 years, with a median of $1.5 million in 2015.
  • Biggest five-year swings in Other Non-Current Liabilities: plummeted 99.99% in 2016 and later soared 116350.0% in 2017.
  • Year by year, Other Non-Current Liabilities stood at $5.8 million in 2014, then plummeted by 74.27% to $1.5 million in 2015, then skyrocketed by 62.98% to $2.4 million in 2016, then plummeted by 88.05% to $292000.0 in 2017, then tumbled by 47.26% to $154000.0 in 2018.
  • Business Quant data shows Other Non-Current Liabilities for ARMP at $154000.0 in Q3 2018, $185000.0 in Q2 2018, and $187000.0 in Q1 2018.